-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 17th, the State Drug Administration issued the Notice on the Protection of Varieties of Traditional Chinese Medicine (Extended Protection Period No. 4) (No. 126 of 2020).
The Notice shows that, in accordance with Article 16 and relevant provisions of the Regulations on the Protection of Chinese Medicines, the cough control produced by the Sixth Chinese Medicine Factory of Tianjin China New Pharmaceutical Group Co., Ltd. has been reviewed by the members of the Committee for the Protection and Review of Chinese Medicines and approved by the State Drug Administration. Sichuan bay drop pills continue to give 2 levels of protection, protection variety number ZYB20720200080, the protection period is November 06, 2020 - June 20, 2026.
2 levels of protection, the protection variety number is ZYB20720200090, the protection period is November 06, 2020 - December 20, 2026.
According to the official website of the Bureau of Drug Administration, up to now, only 124 varieties of Chinese medicine protection have been included in China, with the expiration of the protection period, the number of varieties decreased year by year, it can be seen that the variety of Chinese medicine protection is scarce, competitive advantage is obvious.
chinese medicine protection varieties are protected? The Regulations on the Protection of Chinese Medicine Species clearly state that: For unauthorized imitation of Chinese medicine protection varieties, the administrative department of public health at or above the county level shall be punished according to law for the production of counterfeit medicines, and for enterprises that imitate chinese medicine protection varieties that are clinically in short supply, the approval of the administrative department of health under the State Council is required to obtain such varieties. Approval number, at the same time, imitation enterprise enterprises shall pay reasonable use fees to enterprises that hold the Certificate of Protection of Chinese Medicine Varieties and transfer the prescription composition and process method of the Chinese medicine species, the amount of which shall be agreed upon by both parties; if the parties cannot reach an agreement, the administrative department of health under the State Council shall decide.
。